Cancer Clinical Trial Eligibility Criteria: Washout Periods and Concomitant Medications; Guidance for Industry, IRBs, and Clinical Investigators - Draft Guidance
FDA-2024-D-1376-0002Other
Comments
0
Awaiting comments
Deadline
Closed on Jun 26, 2024
Closed Jun 26, 2024
Net supportiSupport minus oppose · campaigns included
—
Document
Details
The document's own metadata, straight from the source system.
- Title
- Cancer Clinical Trial Eligibility Criteria: Washout Periods and Concomitant Medications; Guidance for Industry, IRBs, and Clinical Investigators - Draft Guidance
- Posted
- Apr 26, 2024
- Comment period
- Apr 26, 2024 – Jun 26, 2024
- Topics
Analysis
Overview
No comments yet.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
Filter:
No comments match.